What is Sinopharm Group Co Price-to-Free-Cash-Flow?
As of today (2024-04-26), Sinopharm Group Co's share price is $2.89.
Sinopharm Group Co's Free Cash Flow per Share for the trailing twelve months (TTM) ended in Sep. 2023 was $0.00. Hence, Sinopharm Group Co's Price-to-Free-Cash-Flow Ratio for today is N/A.
The historical rank and industry rank for Sinopharm Group Co's Price-to-Free-Cash-Flow or its related term are showing as below:
During the past 13 years, Sinopharm Group Co's highest Price-to-Free-Cash-Flow Ratio was 379.47. The lowest was 2.63. And the median was 10.77.
SHTDF's Price-to-Free-Cash-Flow is not ranked *
in the Medical Distribution industry.
Industry Median: 21.23 * Ranked among companies with meaningful Price-to-Free-Cash-Flow only.
During the past 3 years, the average Free Cash Flow per Share Growth Rate was 3.00% per year.
During the past 5 years, the average Free Cash Flow per Share Growth Rate was 98.20% per year.
During the past 10 years, the average Free Cash Flow per Share Growth Rate was 8.50% per year.
During the past 13 years, Sinopharm Group Co's highest 3-Year average Free Cash Flow per Share Growth Rate was 208.00% per year. The lowest was -73.80% per year. And the median was 22.00% per year.
Sinopharm Group Co Price-to-Free-Cash-Flow Historical Data
The historical data trend for Sinopharm Group Co's Price-to-Free-Cash-Flow can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Sinopharm Group Co's Price-to-Free-Cash-Flow
For the Medical Distribution subindustry, Sinopharm Group Co's Price-to-Free-Cash-Flow, along with its competitors' market caps and Price-to-Free-Cash-Flow data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Sinopharm Group Co's Price-to-Free-Cash-Flow Distribution in the Medical Distribution Industry
For the Medical Distribution industry and Healthcare sector, Sinopharm Group Co's Price-to-Free-Cash-Flow distribution charts can be found below:
* The bar in red indicates where Sinopharm Group Co's Price-to-Free-Cash-Flow falls into.
Sinopharm Group Co Price-to-Free-Cash-Flow Calculation
Sinopharm Group Co's Price-to-Free-Cash-Flow ratio for today is calculated as
Sinopharm Group Co's Share Price of today is $2.89. Sinopharm Group Co's Free Cash Flow per Share for the trailing twelve months (TTM) ended in Sep. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.00.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
Sinopharm Group Co (OTCPK:SHTDF) Price-to-Free-Cash-Flow Explanation
Free Cash Flow is considered more important than earnings by value investors. The reason is because, in principle, only the net cash that can be taken from the business belongs to shareholders. This Free Cash Flow can be used to grow the business, reduce debt or return to shareholders in dividends or share buybacks.
In a DCF Calculation Free Cash Flow is used to determine the intrinsic value of companies.
Be Aware
In real business, Free Cash Flow can be affected by the change in accounts receivable, accounts payable, management's decision on expansion, etc. Therefore, investors should look at the Free Cash Flow over the longer term. Long-term average of Free Cash Flow is a more reliable indicator for real free cash flow.
Sinopharm Group Co Price-to-Free-Cash-Flow Related Terms
Thank you for viewing the detailed overview of Sinopharm Group Co's Price-to-Free-Cash-Flow provided by GuruFocus.com. Please click on the following links to see related term pages.
Sinopharm Group Co (Sinopharm Group Co) Business Description
Sinopharm Group was founded in 2003 and listed on the Hong Kong Stock Exchange in September 2009. Its main business is drug distribution in mainland China, which contributes about 75% of total revenue. It is the largest drug distributor, with approximately 20% market share. Other notable segments are medical device distribution, which contributes about 20% of revenue, and retail pharmacies, which contributes about 5%. These are fast-growing industries, where government policy is designed to encourage consolidation and promote large players with scale and efficiency advantages.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
SHTDF has been successfully added to your 